glp-1 news october 21 2025 Alarming rise in weight loss drug overdoses Products - Data Briefs -

FDA-approved peptides (Saxenda, Wegovy, Zepbound) cause gastrointestinal side effects like nausea, vomiting and diarrhea in up to 80% of patients, with rare serious events including gallstones or inflammation of the pancreas

Peptide Works nasal sprays are pre-mixed and ready to use, eliminating preparation errors and saving time

one with glimepiride (with or without metformin)

(2025, Nature Metabolism ) reported daLUXendin and daLUXendin+, non-lipidated and lipidated dual GLP-1/GIP receptor agonist fluorescent probes with nanomolar affinity at both hGLP1R and hGIPR

GLP-1 medications like Ozempic and Wegovy are easier to access than ever thanks to a wave of telehealth services that handle everything from your consultation to your prescription without an office visit